Trade Mark Journal No.2026/029 17 July 2026

UK00004413509 8 July 2026 (5)

LOYARTU

Class 5
Pharmaceutical preparations and substances for the treatment of cancer.

Elevar Therapeutics, Inc.

Representative: Fish & Richardson P.C.